Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
2.010
-0.110 (-5.19%)
Nov 20, 2024, 4:00 PM EST - Market open

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $1.79M in the quarter ending September 30, 2024, a decrease of -62.33%. This brings the company's revenue in the last twelve months to $9.92M, down -30.90% year-over-year. In the year 2023, Taysha Gene Therapies had annual revenue of $15.45M with 517.55% growth.

Revenue (ttm)
$9.92M
Revenue Growth
-30.90%
P/S Ratio
47.78
Revenue / Employee
$190,673
Employees
52
Market Cap
417.06M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DocGo 694.97M
Rigel Pharmaceuticals 157.37M
National Research 144.16M
Quanterix 129.33M
Aquestive Therapeutics 58.90M
Tango Therapeutics 43.38M
Foghorn Therapeutics 25.52M
Allogene Therapeutics 43.00K
Revenue Rankings